FDAorphan designation65% confidence
Medical Products for Rare Diseases and Conditions
Source: FDA
Why This Matters
Why this matters: provides agency context on orphan designation that may shape timing or evidence expectations for Roche.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Infectious Diseases · Hepatitis D
- Sub-indication
- General
Related signal: Roche Launches First Fully Automated HDV Test to Enhance Diagnosis and Monitoring